Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells

Activation of telomerase is a key element in oncogenesis and resistance to apoptosis for many cancers. Some histone deacetylase inhibitors (HDACi) or chemotheraputic agents have been reported to downregulate the expression of human telomerase reverse transcriptase (hTERT). However, whether hTERT is...

Full description

Saved in:
Bibliographic Details
Published inMolecular carcinogenesis Vol. 53; no. 7; pp. 505 - 513
Main Authors Yu, Meng, Kong, Hong, Zhao, Yan, Sun, Xuefei, Zheng, Zhihong, Yang, Chunming, Zhu, Yuyan
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.07.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Activation of telomerase is a key element in oncogenesis and resistance to apoptosis for many cancers. Some histone deacetylase inhibitors (HDACi) or chemotheraputic agents have been reported to downregulate the expression of human telomerase reverse transcriptase (hTERT). However, whether hTERT is involved in cell death of uterine cancer cells induced by combination of HDACi with chemotheraputic regents remain unknown. The present study shows that combining sodium butyrate (NaBu) and adriamycin (ADR) inhibits proliferation of uterine cancer cell lines in a concentration and time‐dependent manner. Growth inhibition was accompanied by caspase‐dependent apoptosis with reduced telomerase activity and decreased hTERT mRNA expression. Ectopic wild type (WT)‐hTERT suppressed the apoptosis induced by NaBu/ADR treatment, while knockdown of hTERT sensitized uterine cancer cells to ADR. Moreover, the addition of NaBu significantly enhanced ADR cytotoxicity for the primary uterine cancer cells with high hTERT expression. These data indicate that downregulation of hTERT is an important part of the mechanism by which NaBu enhances ADR‐induced apoptosis, and suggests that combining NaBu and ADR may be effective in treating uterine tumor with high telomerase activity. © 2013 Wiley Periodicals, Inc.
Bibliography:New Teacher Fund for Doctor Station by Ministry of Education of China - No. 20102104120013
Scientific Research Foundation for Doctoral Program of Liaoning Province of China - No. 20101148
istex:2C89DB041DE3ADB21104E038F04AA0CA05029905
National Natural Science Foundation of China - No. 81000546; No. 31000572; No. 81272834
ark:/67375/WNG-8SWZGJZT-S
Research Foundation of Shenyang City Science and Technology Bureau - No. F12-277-1-20
ArticleID:MC21998
Natural Science Foundation of Liaoning Province - No. 201102273
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0899-1987
1098-2744
DOI:10.1002/mc.21998